Access to anti-retroviral drugs, male in Qatar
Qatar: Access to anti-retroviral drugs, male was 47.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Qatar, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Qatar is 47.0%, measured in 2024. That is the highest value across all 17 years on record.
Compared with earlier readings it is up 2.2% on the previous year and up 9.3% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Qatar peaked at 47.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Qatar 122nd out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Qatar, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2015 | 43.0% | — |
| 2016 | 38.0% | -11.6% |
| 2017 | 36.0% | -5.3% |
| 2018 | 37.0% | +2.8% |
| 2019 | 38.0% | +2.7% |
| 2020 | 42.0% | +10.5% |
| 2021 | 46.0% | +9.5% |
| 2022 | 45.0% | -2.2% |
| 2023 | 46.0% | +2.2% |
| 2024 | 47.0% | +2.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 7 |
| 2010s | 38.4% | 36.0% | 43.0% | 5 |
| 2020s | 45.2% | 42.0% | 47.0% | 5 |
Countries ranked near Qatar
- 119 Libya 49.0% compare
- 120 Belize 48.0% compare
- 120 Kyrgyzstan 48.0% compare
- 122 Jamaica 47.0% compare
- 122 Republic of Moldova 47.0% compare
- 125 Bangladesh 45.0% compare
More gender data for Qatar
- Child population (UN estimates and projections) 510.87 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.71 % change on previous year (2030)
- Population 2,823 (2030)
- Working-age population (UN estimates and projections) 2,823 (2030)
- Population (UN estimates and projections), annual growth rate 0.9268 % change on previous year (2030)
- Age population, age 00, female, interpolated 14,984 (2025)
- Age population, age 00, male, interpolated 15,440 (2025)
- Age population, age 01, female, interpolated 15,715 (2025)
- Age population, age 01, male, interpolated 15,894 (2025)
- Age population, age 02, female, interpolated 16,180 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Qatar?
- Access to anti-retroviral drugs, male in Qatar was 47.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Qatar?
- The highest recorded value was 47.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Qatar?
- The lowest recorded value was 0.0% in 2000.
- How does Qatar rank for access to anti-retroviral drugs, male?
- Qatar ranks 122nd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Qatar?
- Over the last ten years it is up 9.3%. The long-run trend across the full record is volatile.
- Where does this Qatar data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.